These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16380583

  • 1. Early rheumatoid arthritis treatments weighed.
    Mitka M.
    JAMA; 2005 Dec 28; 294(24):3073-4. PubMed ID: 16380583
    [No Abstract] [Full Text] [Related]

  • 2. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    van Vollenhoven RF, Ernestam S, Geborek P, Petersson IF, Cöster L, Waltbrand E, Zickert A, Theander J, Thörner A, Hellström H, Teleman A, Dackhammar C, Akre F, Forslind K, Ljung L, Oding R, Chatzidionysiou A, Wörnert M, Bratt J.
    Lancet; 2009 Aug 08; 374(9688):459-66. PubMed ID: 19665644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In early rheumatoid arthritis the combination of methotrexate and infliximab over 2 years reduces the progression of radiological lesions more than methotrexate alone.
    Montecucco C.
    Clin Exp Rheumatol; 2005 Aug 08; 23(3):289-291. PubMed ID: 15971414
    [No Abstract] [Full Text] [Related]

  • 5. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA, Neovius M, Nilsson JÅ, Petersson IF, Bratt J, van Vollenhoven RF, Ernestam S, Geborek P.
    Ann Rheum Dis; 2013 Dec 08; 72(12):1927-33. PubMed ID: 23196701
    [Abstract] [Full Text] [Related]

  • 6. BeSt practice: the success of early-targeted treatment in rheumatoid arthritis.
    van den Broek M, Lems WF, Allaart CF.
    Clin Exp Rheumatol; 2012 Dec 08; 30(4 Suppl 73):S35-8. PubMed ID: 23078756
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
    Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.
    Ann Rheum Dis; 2015 Jan 08; 74(1):27-34. PubMed ID: 25359382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rheumatoid arthritis: Methotrexate and bridging glucocorticoids in early RA.
    Onuora S.
    Nat Rev Rheumatol; 2014 Dec 08; 10(12):698. PubMed ID: 25385411
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rheumatoid arthritis.
    Emery P, Suarez-Almazor M.
    Clin Evid; 2003 Jun 08; (9):1349-71. PubMed ID: 15366179
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of rheumatoid arthritis.
    Zurier RB, DeMarco DM, Liu NY.
    N Engl J Med; 1996 Sep 12; 335(11):822; author reply 822-3. PubMed ID: 8778595
    [No Abstract] [Full Text] [Related]

  • 13. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
    Shiroky JB.
    J Rheumatol Suppl; 1996 Mar 12; 44():69-71. PubMed ID: 8833057
    [Abstract] [Full Text] [Related]

  • 14. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
    Furst DE.
    Clin Exp Rheumatol; 1999 Mar 12; 17(1):39-40. PubMed ID: 10084027
    [No Abstract] [Full Text] [Related]

  • 15. COBRA combination therapy in daily practice--getting back to the future.
    Boers M.
    Rheumatology (Oxford); 2008 Jan 12; 47(1):1-2. PubMed ID: 18077485
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of rheumatoid arthritis.
    Stohl W, Arkfeld DG.
    N Engl J Med; 1996 Sep 12; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
    [No Abstract] [Full Text] [Related]

  • 17. Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy.
    Boers M, COBRA Study Group. Combinatietherapie Bij Reumatoide Artritis.
    Arthritis Rheum; 2001 Nov 12; 44(11):2703-4. PubMed ID: 11710727
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
    Dahlin J, Sørensen SF.
    Ugeskr Laeger; 2003 Nov 24; 165(48):4646-9. PubMed ID: 14677464
    [No Abstract] [Full Text] [Related]

  • 20. Infliximab treatment of rheumatoid arthritis.
    Maini SR.
    Rheum Dis Clin North Am; 2004 May 24; 30(2):329-47, vii. PubMed ID: 15172044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.